Status:
COMPLETED
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
Lead Sponsor:
North Texas Veterans Healthcare System
Collaborating Sponsors:
University of Texas Southwestern Medical Center
Conditions:
Colon Cancer
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This is a clinical research study to look at the incidence of proteinuria (a condition in which urine contains an abnormal amount of protein) caused by shortened infusions (given into the vein over 10...
Eligibility Criteria
Inclusion
- Patients must be 18 years older
- Patients must be receiving his/her first dose of bevacizumab
- Patients must sign an informed consent
Exclusion
- Patients receiving \> 10 mg/kg doses of bevacizumab
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT00849394
Start Date
November 1 2007
End Date
June 1 2012
Last Update
November 1 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
VA North Texas Health Care System
Dallas, Texas, United States, 75216
2
Parkland Health and Hospital System
Dallas, Texas, United States, 75235
3
UT Southwestern Medical Center
Dallas, Texas, United States, 75390